BUSINESS
Granules India surges as its arm clears audit by US health regulator
Granules India is currently trading at Rs. 380.75, up by 12.75 points or 3.46% from its previous closing of Rs. 368.00 on the BSE. The scrip opened at…
Granules India is currently trading at Rs. 380.75, up by 12.75 points or 3.46% from its previous closing of Rs. 368.00 on the BSE. The scrip opened at…
The Regulatory Authority of Germany (Regierung von Oberbayern) has concluded the follow-on audit of Dr. Reddy’s Laboratories’ Formulations manufacturing facility in Duvvada,…